ER status conversion and subsequent treatment: an assessment of negative ER expression detected by 18F-FES PET in metastatic breast cancer patients with ER-positive primary tumors.
Shuhui YouYizhao XieMengjing JiCheng LiuYannan ZhaoChengcheng GongShihui HuYumeng LiZhongyi YangBi-Yun WangPublished in: Therapeutic advances in medical oncology (2023)
ClinicalTrials.gov identifier: NCT05797987.